Cohance Lifesciences Limited (BOM:543064)

Cohance Lifesciences Statistics

Total Valuation

BOM:543064 has a market cap or net worth of INR 207.56 billion. The enterprise value is 209.43 billion.

Market Cap	207.56B
Enterprise Value	209.43B

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	382.57M
Shares Outstanding	n/a
Shares Change (YoY)	+0.56%
Shares Change (QoQ)	-0.27%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	23.36%
Float	137.07M

Valuation Ratios

The trailing PE ratio is 117.27 and the forward PE ratio is 41.50.

PE Ratio	117.27
Forward PE	41.50
PS Ratio	17.15
PB Ratio	5.29
P/TBV Ratio	8.53
P/FCF Ratio	151.96
P/OCF Ratio	99.93
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 67.54, with an EV/FCF ratio of 153.33.

EV / Earnings	118.33
EV / Sales	17.30
EV / EBITDA	67.54
EV / EBIT	99.50
EV / FCF	153.33

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.11.

Current Ratio	2.92
Quick Ratio	1.59
Debt / Equity	0.11
Debt / EBITDA	1.45
Debt / FCF	3.30
Interest Coverage	18.33

Financial Efficiency

Return on equity (ROE) is 5.51% and return on invested capital (ROIC) is 4.08%.

Return on Equity (ROE)	5.51%
Return on Assets (ROA)	3.26%
Return on Invested Capital (ROIC)	4.08%
Return on Capital Employed (ROCE)	4.26%
Revenue Per Employee	9.99M
Profits Per Employee	1.46M
Employee Count	1,212
Asset Turnover	0.30
Inventory Turnover	0.83

Taxes

In the past 12 months, BOM:543064 has paid 493.10 million in taxes.

Income Tax	493.10M
Effective Tax Rate	23.12%

Stock Price Statistics

The stock price has decreased by -58.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-58.27%
50-Day Moving Average	746.30
200-Day Moving Average	973.71
Relative Strength Index (RSI)	17.92
Average Volume (20 Days)	162,454

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:543064 had revenue of INR 12.11 billion and earned 1.77 billion in profits. Earnings per share was 6.88.

Revenue	12.11B
Gross Profit	8.73B
Operating Income	2.10B
Pretax Income	2.13B
Net Income	1.77B
EBITDA	3.10B
EBIT	2.10B
Earnings Per Share (EPS)	6.88

Balance Sheet

The company has 4.01 billion in cash and 4.51 billion in debt, giving a net cash position of -502.70 million.

Cash & Cash Equivalents	4.01B
Total Debt	4.51B
Net Cash	-502.70M
Net Cash Per Share	n/a
Equity (Book Value)	39.25B
Book Value Per Share	99.19
Working Capital	12.14B

Cash Flow

In the last 12 months, operating cash flow was 2.08 billion and capital expenditures -711.10 million, giving a free cash flow of 1.37 billion.

Operating Cash Flow	2.08B
Capital Expenditures	-711.10M
Free Cash Flow	1.37B
FCF Per Share	n/a

Margins

Gross margin is 72.13%, with operating and profit margins of 17.39% and 14.62%.

Gross Margin	72.13%
Operating Margin	17.39%
Pretax Margin	17.62%
Profit Margin	14.62%
EBITDA Margin	25.61%
EBIT Margin	17.39%
FCF Margin	11.28%

Dividends & Yields

BOM:543064 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.56%
Shareholder Yield	-0.56%
Earnings Yield	0.85%
FCF Yield	0.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.

Last Split Date	Sep 25, 2020
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	5